Group Introduction

We work with global biotechnology (or pharmaceutical) companies to jointly develop global first-of-its-kind (FIC) and best-in-class *(BIC) innovative products. Build an open, cooperative and win-win medical innovation ecosystem to improve the efficiency of pharmaceutical innovation research and development.

We have a management system and professional team that control key nodes in the entire life cycle of innovative products, expert resources in a wide range of specialist disease fields, abundant own cash flow, and profound market awareness. We can gain insight into and explore unmet clinical needs. Products, and efficiently promote the clinical development and commercialization of innovative products, empower the continuous transformation of scientific research results into diagnosis and treatment practice, and benefit more patients.

We are deeply involved in specialized disease fields, such as cardiovascular and cerebrovascular diseases, digestion, central nervous system, skin, ophthalmology, pediatrics, etc., and have gained a leading market position for the main products on sale, allowing the Group's operating performance to continue to grow rapidly. In the past 15 years (2008-2022), the Group's sales and net profit have both achieved compound annual growth rates of more than 20%.

In addition, we operate independently through specialist lines to further integrate superior resources in the field of specialist diseases and create a high-quality specialist team with focus and drive. Benefiting from the collaboration and sharing of group-based resources, we will improve the scale and efficiency of specialized businesses and cultivate major leaders in specialized and small fields; at the same time, our business map will be expanded to the Southeast Asian market, striving to become a "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market and promote the Group's high-quality, sustainable and healthy development.

* Best in Class: Innovative products with innovative preparations, innovative drug delivery methods, etc. to achieve the best treatment effect in class, or the safest, or the most cost-effective